ALBT Avalon GloboCare
- 0.256
- -0.010-3.68%
- 0.261
- +0.005+1.87%
Avalon GloboCare News
Express News | Avalon GloboCare Announces Launch Of U.S. Sales Of KetoAir Breathalyzer At Hack Your Health By KetoCon 2024 Conference
Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference
FREEHOLD, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today
Express News | Avalon GloboCare Shares Are Trading Higher After the Company Announced the Extension of Its Exclusive Distribution Agreement With Qi Diagnostics to Distribute the KetoAir Breathalyzer Device and Related Accessories in North America, South America, the Uni
Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union
Avalon GloboCare Extends Exclusive Distribution Agreement for KetoAir Breathalyzer | NASDAQ:ALBT
Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US
FREEHOLD, N.J., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today
Avalon GloboCare Partners With Qi Diagnostics To Co-Develop International Multi-Center Clinical Studies For DKAir Breathalyzer Device For The Early Detection Of Diabetic Ketoacidosis
Avalon GloboCare Partners With Qi Diagnostics To Co-Develop International Multi-Center Clinical Studies For DKAir Breathalyzer Device For The Early Detection Of Diabetic Ketoacidosis
It's Probably Less Likely That Avalon GloboCare Corp.'s (NASDAQ:ALBT) CEO Will See A Huge Pay Rise This Year
Key Insights Avalon GloboCare will host its Annual General Meeting on 12th of October Total pay for CEO David Jin includes US$360.0k salary The total compensation is similar to the average for the
Apple Approves Use of Avalon GloboCare's KetoAir Mobile Application
KetoAir Mobile Application Launches in Apple App Store KetoAir Mobile Application also Available in the Google Play Store FREEHOLD, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare
Stocks That Hit 52-Week Lows On Thursday
During Thursday's session, 406 companies made new 52-week lows. Key Facts About Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Pfizer (NYSE:PFE).The smallest co
Press Release: Avalon's Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device
Avalon's Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device FREEHOLD, N.J., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Avalo
Wheeler Real Estate Investment Trust Among Real Estate Gainers, Uniti in Losers
Wheeler REIT Among Real Estate Gainers, Xinyuan in Losers
Reason Why Avalon GloboCare Corp ($ALBT) Surged Today
Top Midday Gainers
Olema Pharmaceuticals (OLMA) unveiled Tuesday a stock purchase agreement for a private placement of about $130 million of its common stock to selected institutional investors. The company also signed
CGC, VNDA and TSE Among Mid-day Movers
Hannon Armstrong, Apple Hospitality Among Real Estate Gainers; Safehold in Losers
Avalon GloboCare Shares Soar on Patent Notice
By Dean Seal Shares of Avalon GloboCare rose by a quarter after patent authorities issued a notice of publication for one of the company's patents over receptor proteins. The stock was up 25% at $1.
Avalon GloboCare Announces Notice of Publication for Key U.S. Patent Filed Jointly With the Massachusetts Institute of Technology (MIT)
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor MoleculesFREEHOLD, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NA
Avalon's Laboratory Services MSO Launches Innovative Laboratory Test for Tuberculosis
New Proprietary Testing Method Makes Tuberculosis Diagnosis Easier and Faster New Test Method Expected to Generate Revenue in 2023 FREEHOLD, N.J., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp.
Analysis
Price Target
No Data
